Submission Details
| 510(k) Number | K051969 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 20, 2005 |
| Decision Date | October 03, 2005 |
| Days to Decision | 75 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Statement |
K051969 is an FDA 510(k) clearance for the TRICAT RIA (ADRENALIN/NORADRENALIN/DOPAMINE); KATCOMBI RIA (ADRENALIN/NORADRENALIN); NORADRENALIN RIA, a Chromatographic/fluorometric Method, Catecholamines (Class I — General Controls, product code CHQ), submitted by Ibl GmbH (East Stroudsburg, US). The FDA issued a Cleared decision on October 3, 2005, 75 days after receiving the submission on July 20, 2005. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1165.
| 510(k) Number | K051969 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 20, 2005 |
| Decision Date | October 03, 2005 |
| Days to Decision | 75 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Statement |
| Product Code | CHQ — Chromatographic/fluorometric Method, Catecholamines |
| Device Class | Class I — General Controls |
| CFR Regulation | 21 CFR 862.1165 |